Sources of Funding
The present study was supported by the Swedish Foundation for Strategic Research (RB13‐0197) and Swedish Association of Local Authorities and Regions. The PLATO (Platelet Inhibition and Patient Outcomes) trial and the biomarker analyses were sponsored by AstraZeneca. The authors are solely responsible for the design and conduct of this study, all study analyses, the drafting and editing of the manuscript, and its final contents.